Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026)

BioAge Labs' Other Non-Current Assets history spans 3 years, with the latest figure at $216000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 10.0% to $216000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $216000.0, a 10.0% decrease, with the full-year FY2025 number at $216000.0, down 10.0% from a year prior.
  • Other Non-Current Assets hit $216000.0 in Q4 2025 for BioAge Labs, down from $227000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BIOA hit a ceiling of $3.3 million in Q4 2023 and a floor of $216000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $743166.7 across 3 years, with a median of $238000.0 in 2025.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 92.73% in 2024 and later fell 10.0% in 2025.
  • Tracing BIOA's Other Non-Current Assets over 3 years: stood at $3.3 million in 2023, then plummeted by 92.73% to $240000.0 in 2024, then dropped by 10.0% to $216000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BIOA at $216000.0 in Q4 2025, $227000.0 in Q3 2025, and $237000.0 in Q2 2025.